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A B S T R A C T
DNA methylation is currently the most promising molecular marker for monitoring aging and predicting life
expectancy. However, the mechanisms underlying age-related DNA methylation changes remain mostly un-
discovered.
Here we discuss the current knowledge of the dynamic nature of DNA epigenome landscape in mammals, and
propose putative molecular mechanisms for aging-associated DNA epigenetic changes. Specifically, we describe
age-related variations of methylcytosine and its oxidative derivatives in relation to the dynamics of chromatin
structure, histone post-translational modifications and their modulators.
Finally, we are proposing a conceptual framework that could explain the complex nature of the effects of age
on DNA methylation patterns. This combines the accumulation of DNA methylation noise and also all of the
predictable, site-specific DNA methylation changes.
Gathering information in this area would pave the way for future investigation aimed at establishing a
possible causative role of epigenetic mechanisms in aging.
1. Epigenetic DNA modifications
1.1. Origin and function of 5-methylcytosine
DNA methylation is one of the heritable epigenetic marks of the
genome linked to gene expression/regulation and developmental pro-
cesses in various eukaryotes.
This DNA modification is achieved through the addition of a methyl
group to cytosine, resulting in the formation of 5-methylcytosine (5mC)
(Schubeler, 2015) (Fig. 1).
In mammals, methylated cytosines are mainly formed on CpG di-
nucleotides (CG) by the activity of the DNA methyltransferase enzymes
DNMT1, 3A and 3B (DNMTs). CG sites are under-represented in
mammals and tend to cluster in regions that are frequently located next
to gene promoters and show atypically high CG frequency. These re-
gions are known as CpG islands (CGIs) (Deaton and Bird, 2011;
Schubeler, 2015). Of the approximately 28 million CG sites present in
the human genome, 20–40% are generally unmethylated in contrast to
the hypermethylated remainder of the genome (Deaton and Bird, 2011;
Schubeler, 2015; Smith and Meissner, 2013).
This specific DNA methylation patterning in mammals relates to
specific functions. Global genomic hypermethylation mainly concerns
non-genic regions corresponding to heterochromatin. The 5mC role in
such context is to preserve whole genome integrity at different levels as
it avoids aberrant X-chromosome activation, transcription of endo-
parasitic repeated DNA and prevents aberrant centromeres re-
combination (Blasco, 2007; Jaco et al., 2008; Yoder et al., 1997).
Conversely, non-methylated CGIs allow the expression of almost
60% of genes in vertebrates, generally involved in housekeeping roles.
It is rare for CGIs to undergo methylation. But when this occurs it en-
sures a stable transcriptional repression of genes that must remain si-
lent, i. e. for tissue specific genes and oncogenes (Deaton and Bird,
2011). This precise partitioning does not concern regions right beside
the CGIs and with lower CG dinucleotides content known as the CGI
shores and shelves. These regions present variable 5mC levels and
patterns that possibly govern tissue specific gene expression (Irizarry
et al., 2009).
Beyond the CGIs, 5mC positioning on genes occurs preferentially on
exons over introns (Jones, 2012; Lister et al., 2009), which is likely to
modulate alternative splicing (Maunakea et al., 2010).
Furthermore, DNA methylation brings into play gene expression
modulation even away from promoters as it influences the activity of
distal regulatory elements such as enhancers, silencers and insulators
(Weaver and Bartolomei, 2014).
https://doi.org/10.1016/j.mad.2017.12.002
Received 30 October 2017; Received in revised form 14 December 2017; Accepted 16 December 2017
⁎ Corresponding author at: Department of Cellular Biotechnologies and Haematology, University of Rome ‘La Sapienza’, V.le Regina Elena 324, 00161 Rome, Italy.
E-mail address: zampieri@bce.uniroma1.it (M. Zampieri).
Mechanisms of Ageing and Development xxx (xxxx) xxx–xxx
0047-6374/ © 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Please cite this article as: Ciccarone, F., Mechanisms of Ageing and Development (2017), https://doi.org/10.1016/j.mad.2017.12.002
The initial establishment of DNA methylation patterns takes place
during development and differentiation and is likely determined by the
activity of the so called “de novo” methyltransferases DNMT3A and
DNMT3B (Clark, 2015). DNMT1 manages their maintenance over the
course of DNA replication, thus ensuring DNA methylation pattern
propagation. DNMT1 performs re-methylation of hemi-methylated CG
sites generated during DNA replication after binding to the adaptor
proteins Proliferating Cell Nuclear Antigen (PCNA) and Ubiquitin Like
With PHD And Ring Finger Domains 1 (UHRF1) (Schubeler, 2015).
Despite the fact that DNMTs have well partitioned activities, there is
some evidence of their functional redundancy. Indeed, methylation
maintenance seems to involve DNMT3A and 3B, while “de novo” me-
thylation might be carried out by DNMT1 (Sharma et al., 2011).
Therefore, DNA methylation patterns are the combinatorial result of
both methylation establishment and maintenance.
However, the molecular events that govern regional and temporal
evolution of DNA methylation patterns are not completely understood,
despite the fact that some evidence indicates that DNA methylation
processes may rely on pre-established chromatin modifications such as
histone post-translational modifications (PTMs) (Rose and Klose, 2014).
In fact, studies conducted on lower eukaryotes reveal that pre-ex-
isting H3K9 histone methylation is crucial for the recruitment of
DNMT3A and 3B on DNA, thus suggesting a mutual relationship be-
tween DNA methylation and histone PTMs (Lindroth et al., 2004;
Tamaru et al., 2003). Similar evidence indicates that in several mam-
malian cell lines the SuUV39H1/2 histone methyltransferase is required
for DNA methylation at pericentric heterochromatin, through the pla-
cement of H3K9 trimethylation (H3K9me3) (Fuks et al., 2003). In ad-
dition, a direct interaction between DNMT3A/3B and SUV39H1,
SETDB1 and G9a/GLP H3K9 methyltransferases would appear to be
crucial for carrying out de novo DNA methylation (Chang et al., 2011;
Lehnertz et al., 2003; Li et al., 2006).
The synergic interaction between these two classes of enzymes also
extends to DNMT1 for carrying out gene repression (Smallwood et al.,
2007).
Similarly, H3K36 trimethylation (H3K36me3), catalysed by the
histone methyltransferase SETD2, acts as a recruitment mark for
DNMT3A/B (Dhayalan et al., 2010) and correlates with DNA methy-
lation enrichment on gene bodies, crucially involved in the splicing
machinery modulation (Brown et al., 2012).
Several observations suggest that histone methylation may play a
role in contrasting the recruitment of DNA methylation enzymes to
certain genomic regions. As such studies describe, H3K4 trimethylation
(H3K4me3) seems to exclude DNMTs' action, thus preventing DNA
methylation of the CGIs (Ooi et al., 2007).
Another chromatin epigenetic modification that inhibits DNA me-
thylation occurs on lysine 27 of histone H3 (H3K27me) and is catalysed
by the EZH1/2 components of the Polycomb repressive complex 2
(PRC2) (Statham et al., 2012). Curiously, H3K27me3 as well as other
molecular events and histone PTMs have been found to provoke “de
novo” methylation of CGIs in cancer (Schlesinger et al., 2007).
Such interplay between DNA methylation and chromatin config-
uration also concerns maintenance pathways since DNMT1 activity
depends on several molecular factors in the resolution of CG dinu-
cleotides hemi-methylation (Jeltsch, 2006). UHRF1 seems to carry out
these tasks on behalf of DNMT1 as it recognises specific histone PTMs.
The C-terminal Ring domain of UHRF1 works as an E3 ligase and
performs histone H3K23 ubiquitylation, which favours DNMT1 re-
cruitment on hemi-methylated CG. H3K23 ubiquitylation antagonises
the auto-inhibitory effect of the DNMT1’s RFTS domain (The Replica-
tion Focus Targeting Sequence) (Liu et al., 2013b; Nishiyama et al.,
2013).
However, there is a mutual relationship existing between DNA
methylation and chromatin configuration. In fact, 5mC is recognised by
some methylated-CG DNA binding proteins, such as the members of the
MBD (MeCP2 and Mbd1–4) and BTB/POZ (Kaiso and ZBTB4/38) fa-
milies. Several methylated-CG DNA binding proteins seem to act as a
recruiter for histone deacetylases and histone lysine methyltransferases.
This leads to chemical and structural remodelling of chromatin by in-
troducing epigenetic marks functionally linked with transcriptional
repression and heterochromatin formation (Bogdanovic and Veenstra,
2009).
1.2. 5-Methylcytosine removal and oxidation
To reverse DNA methylation, both passive and active mechanisms
take place in the cell (Fig. 1). More specifically, passive demethylation
occurs when DNA replication is uncoupled from DNA methylation
maintenance. The outcome of such non-catalytic events leads to 5mC
removal over the course of cellular replication (Clark, 2015; Schubeler,
2015).
The catalytic 5mC replacement with cytosine is the active de-
methylation process and involves iterative 5mC oxidative steps. This
chain of reactions involves a group of enzymes, the Ten-Eleven
Translocation (TET) dioxygenases (TET1, TET2 and TET3). The first
oxidative step is the 5mC conversion to 5-hydroxymethylcytosine
(5 hmC). Following this first event, demethylation occurs when 5hmC is
oxidized further by TET proteins, subsequently forming 5-for-
mylcytosine (5fC) and 5-carboxylcytosine (5caC). Unmethylated cyto-
sine replaces these two compounds when the thymine DNA glycosylase
(TDG) triggers the base excision repair (BER) process (Delatte et al.,
2014). An additional mechanism might involve 5mC and 5hmC dea-
mination by the AID/APOBEC (Activation-induced deaminase/apoli-
poprotein B editing complex) enzymes. Deamination forms thymine
and 5-hydroxymethyluracil (5hmU), which are then removed from
DNA by the BER/TDG activity (Delatte et al., 2014).
However, 5hmC is not merely a demethylation intermediate. A
growing body of evidence highlights that 5hmC may act as a stable
epigenetic signal. Thus, on a par with 5mC, 5hmC is recognised as an
additional base of DNA (Shen and Zhang, 2013).
However, 5hmC levels very dramatically vary among mammalian
cell types and tissues, with the highest recorded content in the central
nervous system (CNS) (Globisch et al., 2010; Munzel et al., 2010). In
the brain, 5hmC is enriched on transcriptional starting sites as well as
gene bodies of actively transcribed genes. More specifically, on gene
bodies 5hmC localizes at exon-intron boundaries. 5hmC locates also
around flanking regions of transcriptional regulatory elements, such as
Fig. 1. Model of DNA methylation/demethylation pathways. DNA methyltransferases
(DNMTs) form 5-methylcytosine (5mC) from cytosine (C). Iterative oxidations by TET
dioxygenases produce 5- hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC). Passive DNA demethylation can occur by a reduction in activity,
failed recruitment onto DNA or absence of DNMTs during cell divisions. 5hmC, 5fC and
5caC are no longer recognized by DNMT enzymes and can induce passive DNA de-
methylation as well. Active demethylation can be achieved through the removal of 5fC
and 5caC by the Thymine DNA Glycosylase (TDG) followed by the base excision repair
(BER) pathway. Alternatively, 5mC and 5hmC can be deaminated by AID/APOBEC en-
zymes to form thymine (T) and 5-hydroxymethyluracil (5hmU), respectively. Both T and
5hmU can be excised by the TDG/BER pathway.
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enhancers/silencers and transcription factor binding sites. Similar pat-
tern occurs on CGIs, where 5hmC is positioned at their borders. In
contrast, a reduced 5hmC presence is observed in repeated sequences
such as SINE, LINE, LTR and satellite DNA (see (Shen and Zhang, 2013)
and references therein).
The mechanisms behind 5hmC patterning haven't been character-
ized as yet. However, evidence suggests that 5hmC positioning is in-
fluenced by DNA sequence as well as chromatin epigenetic protein
factors such as PRC2 (Neri et al., 2013; Williams et al., 2011b).
It is plausible to assume that this epigenetic signal influences
chromatin structure and function. For example, 5hmC recognition and
binding by MeCP2 in the brain is functionally associated with tran-
scription (Mellen et al., 2012).
In regards to 5fC and 5caC, their extreme scarcity in mammalian
genomes limits an understanding of their roles. However, several stu-
dies suggest that these demethylation intermediates might be stable on
mammalian genome, thus paving the way for further studies to better
understand their functions beyond demethylation (Bachman et al.,
2015).
1.3. DNA epigenetic modifications as changeable components of the
epigenome
Genomic DNA methylation landscape is highly dynamic, under-
going both physiological changes and disease-associated alterations.
Large scale reprogramming occurs during early stages of develop-
ment. In fact, the genome of pre-implantation embryos undergoes
massive demethylation in order to re-establish cell totipotency (Feng
et al., 2010). Formation of totipotent gametes also requires a radical
genome-wide DNA demethylation (Ciccarone et al., 2012; Feng et al.,
2010). If we combine these observations, demethylated genomes are
the starting point to reconstruct cell specific epigenetic patterns during
further developmental and differentiation stages.
Outside of these physiological events, DNA methylation patterns
have long been considered static except for pathological conditions,
most notably in cancer.
One of the most crucial factors that modifies DNA methylation
patterns is the environment (Feil and Fraga, 2012; Leenen et al., 2016),
but the mechanisms behind this influence still do not point to a clear
mechanism. A groundbreaking study on the association between me-
thylome and environment was conducted by Fraga et al. on mono-
zygotic twin pairs. Despite these individuals having the same genetic
backgrounds, their methylation status gradually diverges with in-
creasing age as a consequence of different environments and lifestyles
(Fraga et al., 2005). A possible interaction between environment and
age-related methylation divergence was confirmed by a longitudinal
study (Martino et al., 2013).
A number of environmental cues have been associated with DNA
methylation changes. These events include chemical (e.g. pollutants
and food additives), physical (e.g. UV radiations and temperature),
biological (e.g. viral infections, microbiota and genetic effects), psy-
chological (e.g. mood disorders) and behavioural (lifestyle, overeating,
high-fat diet, famine, caloric restriction, physical activity and circadian
rhythms) factors (Feil and Fraga, 2012; Leenen et al., 2016).
Some of the above mentioned environmental factors are strongly
associated with a higher risk of disease. For example, exposure to ar-
senic has been linked to an increased cancer risk, possibly due to DNA
hypermethylation of oncosuppressor genes (Marsit et al., 2006). The
same phenomenon has been associated with environmental pollution
by asbestos and chronic exposure to sun or UV rays (Chanda et al.,
2006; Gronniger et al., 2010).
Recently, it was also discovered that the genetic variation might
influence the epigenome, as a number of single nucleotide poly-
morphisms have been associated with a deregulated DNA methylation
maintenance at several smoking-associated CGs (van Dongen et al.,
2016).
It is interesting to note that mammalian methylome dynamicity
extends not only to postnatal life but also prenatally as dietary habits
during pregnancy strongly determine the genome methylation status of
offspring (Aagaard-Tillery et al., 2008).
An important natural case study in the field of prenatal epigenomics
is the ‘Dutch Hunger Winter’ study. Individuals that experienced in
utero exposure to famine had an increased incidence of several health
problems such as obesity, hypertension, cardiovascular diseases and
impaired glucose homeostasis. With regard to epigenetic variations, the
genomes from the same group of people showed hypomethylation and
hypermethylation of several loci associated with specific pathways
(Heijmans et al., 2008; Tobi et al., 2009).
Similarly, individuals that experienced in utero depression of their
mothers also had altered methylation levels at imprinted genes, likely
predisposing them to a higher risk of chronic diseases during adulthood
(Liu et al., 2012).
Along with the environmental influences exercised on prenatal
epigenome, it would be interesting to prove trans-generational in-
heritance of epigenetic changes in mammals as already described in
plants and nematodes (Heard and Martienssen, 2014). Despite the fact
that germline methylome resetting in mammalian embryos might ex-
clude this possibility, some sequences in mouse genome, such as in-
tracisternal A particle (IAP) retrotransposons, are pretty much resistant
to such DNA methylation reprogramming. This relevant discovery
opens up the possibility that some postnatally acquired epigenetic
changes might be passed from one generation to another (Lane et al.,
2003; Morgan et al., 1999).
As the epigenome is dynamic by nature, it is reasonable to speculate
that some environmental or behavioural factors might induce beneficial
epigenetic outcomes via changes of DNA methylation patterns. For in-
stance, long-term physical activity is associated with lower cancer risk
and mortality via methylation changes at a number of genes involved in
metabolism, muscle growth, haematopoiesis and inflammation (Aoi
et al., 2010; Keller et al., 1985; Nakajima et al., 2010; Smith et al.,
2008). Even the methylation status of the mitochondrially encoded
gene NADH dehydrogenase 6 (MT-ND6) changes as a result of regular
physical activity (Pirola et al., 2013).
Recently, it has been discovered that natural patterns of sleep
modulate the methylome in the brain. In fact, a regular 24-hour rhythm
of DNA methylation reprogramming positively affects gene expression
in the human brain and its disruption is associated with Alzheimer’s
disease (Lim et al., 2014).
An advantageous modulation of DNA methylation patterns has also
been suggested in the case of nutritional factors. This relationship is
well known in many organisms, but it still remains a subject of study in
humans (Bacalini et al., 2014). Indeed, a diet rich in vegetables and
plant oil influences methylation on CG sites functionally related to
genomic integrity maintenance in humans (Switzeny et al., 2012).
These epigenetic changes are adaptive and they could prolong lifespan,
promoting better health.
All these observations point towards the intriguing hypothesis that
the epigenome might be the molecular interface between the environ-
ment and DNA, where their interactions are recorded as a type of epi-
genetic memory.
2. The DNA methylation landscape of the aging genome
2.1. The impact of aging on DNA epigenetic modification patterns
Aging is a complex physiological process characterised by a pro-
gressive loss of tissue functionality and an increased risk of death. Many
intrinsic and extrinsic cues, both genetic and stochastic factors, are
linked to progressive physiological, mechanical and cognitive age-as-
sociated decline. Moreover, age represents one of the main risk factors
of a number of diseases, including cancer, atherosclerosis as well as
Alzheimer's disease (Niccoli and Partridge, 2012).
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Many efforts in the last years have been spent in identifying age-
associated deregulation of the epigenetic landscape, which is now re-
cognised as a hallmark of the aging process. Changes of epigenetic
patterns occur practically all through the entire lifetime in all species,
tissues and cell types (Christiansen et al., 2016; Maegawa et al., 2010).
In humans, DNA methylation changes start early in life, as demon-
strated by a longitudinal study (five years duration) of infants’ blood
where increased levels of 5mC were shown to have already occurred
during the first year of life (Herbstman et al., 2013; Martino et al.,
2011). These early changes have also been documented in monozygotic
twins. Notably, their epigenetic profiles continue to accumulate
changes with the advancement of age causing diverging patterns, even
more so in twins that did not share the same habits and/or environ-
ments (Fraga et al., 2005; Tan et al., 2016). This would indicate that
aging-associated DNA methylation changes are caused in part by en-
vironmental factors.
Early studies investigating the relationship between DNA methyla-
tion and aging in mammals date back to the 1980’s, showing that se-
nescent normal fibroblasts and various tissues in aged mice presented
low levels of 5mC (Wilson and Jones, 1983; Wilson et al., 1987). Since
these pioneering studies, knowledge of age-associated epigenetics has
grown enormously, thanks mainly to developments in the area of
genome-wide technologies. A lot of new data now proves that DNA
methylation patterns are altered during aging in a wide range of tissues
and species (Ben-Avraham et al., 2012; Day et al., 2013). This emerging
scenario indicates that during the aging process mammalian genome
undergoes an erosion of DNA methylation patterns along with direc-
tional, locus-specific hypermethylation and hypomethylation (Day
et al., 2013; Johansson et al., 2013; Jones et al., 2015; Zampieri et al.,
2015).
Age-associated hypomethylation occurs in heterochromatic regions
of the genome, such as repetitive elements and transposons, which
contain the majority of methylated CG dinucleotides in human DNA
(Bollati et al., 2009; Heyn et al., 2012). In addition to repetitive ele-
ments, loss of methylation with aging was also demonstrated in CG-
poor regions located next to genes (Day et al., 2013; Heyn et al., 2012)
together with “open sea regions”. These are regions of megabase ex-
tension characterised by low CG content and are also demethylated in
cancer (Yuan et al., 2015).
Conversely, focal hypermethylation in aging mainly occurs at gene-
associated CGIs (Madrigano et al., 2012), which are normally un-
methylated. A number of genes hypermethylated with age also undergo
methylation events in cancer cells and in other age-related diseases
(Post et al., 1999; So et al., 2006; Zampieri et al., 2015).
These age-dependent methylation changes at promoter regions may
have an impact on transcriptional programmes. In fact, impaired im-
munocompetence in the older generation has been linked to repression
of immune cell differentiation genes along with activation of auto-
immunity genes dependent upon alterations of DNA methylation pat-
terns (Marttila et al., 2015; Tserel et al., 2015; Wei et al., 2012; Zhang
et al., 2002; Zhao et al., 2016). However, aging-related DNA methyla-
tion changes are not necessarily associated with transcriptional changes
(Horvath, 2013; Peters et al., 2015; Yuan et al., 2015). This is probably
because other layers of epigenetic regulation, such as histone PTMs,
may subsist (Johansson et al., 2013; Rakyan et al., 2010; Teschendorff
et al., 2010; Yuan et al., 2015).
Most of the conclusions drawn so far about DNA methylation in
aging may be biased by the fact that the methods used for detecting
5mC are not capable of excluding 5hmC contribution. This is particu-
larly true for analyses performed in the brain where the 5hmC levels are
abundant and increase with aging both in mice (Chen et al., 2012;
Szulwach et al., 2011) and humans (Wagner et al., 2015). However,
several reports have demonstrated a global 5hmC decrease with age in
non-neural tissues such as blood (Buscarlet et al., 2016; Valentini et al.,
2016; Xiong et al., 2015).
The first genome-wide analysis focusing on 5hmC in aging has been
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Fig. 2. Schematics of DNA methylation patterns in early life and ageing. A representative chromosome of monozygotic twins was shown to highlight epigenetic alterations in aging
occurring independently of genetic background. Interspersed, telomere and centromere associated DNA repeats as well as CGIs and CG poor promoters, associated with altered gene
expression in aging are reported. In early life (upper panel), DNA methylation distribution of the twins is comparable. In fact, the CGI promoters of housekeeping genes are protected from
DNA methylation and are generally associated with active transcription. In contrast, repetitive elements (LTR, SINE and LINE), telomeric and centromeric heterochromatin regions and
CG-poor promoters of repressed genes are typically methylated. In aging (lower panel), epigenetic drift alters the DNA methylation patterns leading to divergences despite identical
genetic backgrounds. In particular, DNA repeats undergo a generalised hypomethylation, while locus specific epigenetic changes are observed in gene-associated regulatory regions.
Moreover, a number of CG sites (*) exhibit reproducible DNA methylation changes across individuals culminating in the epigenetic clock. Arrows indicate transcription start sites. The
colour green indicates active transcription, while the colour red indicates repressed transcription.
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performed on human mesenchymal stem cells (hMSCs). It showed that
aging is associated with equal amounts of both 5hmC gain and loss. In
particular, hypo-hydroxymethylated sites were largely enriched at CG-
poor regions while hyper-hydroxymethylated sites tended to occur at
CGIs and gene bodies (Torano et al., 2016).
Currently, the epigenetic theory of aging is the result of two op-
posing phenomena. On one hand, baseline DNA methylation levels
progressively diverge during aging. This process, known as “epigenetic
drift”, also occurs in individuals with identical genetic backgrounds
such as monozygotic twins (Fraga et al., 2005). On the other hand,
some locus-specific DNA methylation changes are highly reproducible
across aged people, independently of gender and tissue type. This
phenomenon could point to the existence of a programmed epigenetic
reconfiguration during aging that has given rise to the “epigenetic
clock” theory (Horvath, 2013) (Fig. 2).
Epigenetic drift leads to inter-individual epigenetic divergence as
age increases and is likely determined by a life-long epimutation ac-
cumulation (Fraga et al., 2005; Jones et al., 2015) due to environmental
factors and/or intrinsic stochastic factors (Fraga et al., 2005; Tan et al.,
2016). Curiously, recent studies suggest that in later stages of life the
whole process paradoxically culminates in an inter-individual con-
vergence of epigenomes, a phenomenon termed as “epigenetic assim-
ilation”. In fact, reduced epigenetic variability was observed in very old
twin pairs (Talens et al., 2012), even when they were discordant for the
aging-associated disease of Alzheimer (Oh et al., 2016). Notably, even
the inter-tissue epigenetic variability of cerebral cortex and cerebellum
was affected (Oh et al., 2016), suggesting that the reduced epigenetic
complexity of tissues may lead to cell de-differentiation and loss of cell
identity in very old people.
Together with the accumulation of stochastic, age-dependent epi-
genetic variability due to the drift, part of the aging-associated DNA
methylation changes are definite and probably programmed. In fact, a
number of studies have broadly proved the existence of an age-asso-
ciated epigenetic reprogramming consisting of DNA methylation
changes at specific CG sites that are reproducible across individuals and
tissues (Bysani et al., 2017; Garagnani et al., 2012; Steegenga et al.,
2014). Of greater significance, in 2013, two predictive mathematical
models of biological age, based on aging-associated site-specific DNA
methylation changes, highlighted the existence of the “epigenetic
clock”(Hannum et al., 2013; Horvath, 2013). These age prediction tools
interrogate the DNA methylation state of a number of CG sites. Speci-
fically, the Hannum’s clock assesses 71 CGs and is mainly applicable to
whole blood, while the multi-tissue Horvath’s clock assesses 353 CGs, of
which those hypermethylated with aging are highly compatible with a
broad spectrum of tissues (Horvath, 2013). Additional mathematical
models estimating DNA methylation age have been proposed to achieve
the following aims: i) to restrict the number of CGs under investigation,
thus setting up cost effective methodologies suitable for both clinical or
forensic purposes (Durso et al., 2017; Weidner et al., 2014); ii) to ex-
pand the number of analyzable target tissues in order to use them in
specific research fields as in the case of teeth for anthropological ap-
plications (Giuliani et al., 2016); iii) to extend epigenetic age predictors
to other species (Stubbs et al., 2017).
DNA methylation predicts biological age more efficiently than
chronological age. In fact, the rates of epigenetic age acceleration, re-
presenting the gap between DNA methylation age and the chronological
one, has been associated with symptoms of aging, such as frailty and
menopause (Breitling et al., 2016; Levine et al., 2016), as well as to
several aging-associated pathologies including cancer and neurode-
generative diseases (Ambatipudi et al., 2017; Horvath, 2013; Levine
et al., 2015). Moreover, the DNA methylation age can predict life ex-
pectancy because it was shown to predict all-cause mortality in-
dependently of common risk factors (Chen et al., 2016; Christiansen
et al., 2016; Lin et al., 2016; Marioni et al., 2015).
2.2. DNA methylation changes in cellular and disease models of aging
Aging is accompanied by a debilitating loss of cellular integrity and
function, which induces age-related degeneration of tissues and organs,
manifesting in age-related pathologies, such as sarcopenia, osteoporosis
and neurodegeneration. At the cellular level, senescence is a process
that can actively contribute to aging phenotypes as the number of se-
nescent cells in the body increases with age and it has been suggested
that senescence underlies many aging-related diseases. Cellular senes-
cence refers to a cell proliferation arrest which is essentially irreversible
and occurs when cells experience various types of stresses including the
replication-associated shortening of telomeres (replicative senescence),
activation of oncogenes and a permanently maintained DNA damage
response state (Campisi, 2013).
Cellular senescence shares epigenetic similarities with aging. Early
studies showed that the replicative senescence process is associated
with loss of DNA methylation similar to what is observed in aging
(Nilsson et al., 2005; Wilson and Jones, 1983). In fact, senescence can
be induced by treating cells with DNA methylation inhibitors (Vogt
et al., 1998).
More recent analyses confirmed that aging and cell senescence, in-
duced by long-term culture conditions, share similar methylation
changes at specific CGIs and may lead to transcriptional deregulation
(Bork et al., 2010; Koch et al., 2011; Wagner et al., 2009). In addition,
epigenetic changes observed both in aging and in senescence can be
reversed when cells are reprogrammed to form induced pluripotent
stem cells (iPSCs) (Frobel et al., 2014; Horvath, 2013; Koch et al., 2013;
Weidner et al., 2014).
Recent epigenetic clock analyses of different in vitro senescence
models of primary endothelial cells, demonstrated that both replicative
and oncogene-driven senescence are actually associated with an in-
creased epigenetic age, suggesting that senescent cells alter their DNA
methylation state in an age-dependent manner (Lowe et al., 2016).
However, the relationship between age- and senescence-associated
DNA methylation changes seems to be less extensive than was pre-
viously believed. In fact, in contrast to replicative and oncogene-in-
duced senescence, DNA damage-dependent senescence was not ac-
companied by epigenetic aging. Moreover, progression of DNA
methylation age in long-term cultures of cells, maintaining telomere
integrity, occurs in the absence of any typical signs of senescence (Lowe
et al., 2016). This indicates that cellular epigenetic aging is not asso-
ciated with senescence, even though the epigenetic clock speed can be
affected by some senescence-associated factors. Similar conclusions can
be drawn from studies showing that senescent cells are characterised by
specific epigenetic signatures (Franzen et al., 2017; Koch et al., 2013)
able to predict the number of replication rounds of both fibroblasts and
hMSCs independently from the age of donors (Koch et al., 2012;
Schellenberg et al., 2014).
Premature aging-related phenotypes characterise a number of rare
genetic disorders known as progeroid syndromes, which are mainly
caused by defects in lamin proteins or in DNA repair factors. In some
progeroid syndrome patients, accelerated aging has not been associated
with any genetic aberration, thus suggesting a possible contribution by
epimutations.
In this context, a relevant epigenetic study was performed in im-
mortalised B-cells from Werner syndrome (WS) and Hutchinson–Gilford
progeria syndrome (HGPS) patients who were harbouring, or not har-
bouring, mutations in the RecQ helicase like (WRN) and Lamin A
(LMNA) genes. Genome-wide analysis of DNA methylation patterns
revealed that mutated patients share some epigenetic similarities and
differ from controls. On the contrary, non-mutated samples showed
barely distinguishable DNA methylation patterns when compared to
controls. This indicates that genetic mutations causing progeroid syn-
dromes might have a causal role in the establishment of disease-specific
methylomes. Indeed, WS/HGPS mutated samples and naturally aged
individuals shared various differentially methylated CGs mostly in
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inflammation-related genes putatively relevant in aging (Heyn et al.,
2013). In addition, investigations on whole blood from WS patients
revealed that methylation changes are recurrent in specific loci asso-
ciated with sphingolipid metabolism and signalling pathways that
might explain the scleroderma-like changes occurring in WS
(Guastafierro et al., 2017). Moreover, recent evidence shows that WS
holds an accelerated epigenetic age (Maierhofer et al., 2017).
Besides typical progeroid syndromes, further evidence comes from
epigenetic studies of Down Syndrome (DS). DS is actually considered a
premature aging disease with aging-related features that particularly
affect CNS and the immune system. DS is the most common chromo-
somal disorder originating from the presence of all or part of an extra
chromosome 21.
Regarding DNA methylation, DS-related changes are already de-
tected in foetal and early postnatal developmental stages as well as in
extra-embryonic tissues (El Hajj et al., 2016; Jin et al., 2013; Mendioroz
et al., 2015). Changes extend to post-natal life as suggested by the
identification of several DS-associated differentially methylated regions
in adult somatic tissues (Bacalini et al., 2015; Jones et al., 2013; Kerkel
et al., 2010; Mendioroz et al., 2015). DNA methylation variations were
not limited to chromosome 21 and include both 5mC gains and losses,
the latter highly represented in brain and placenta (Bacalini et al.,
2015; Jin et al., 2013; Mendioroz et al., 2015). As observed in WS, some
tissues from DS patients exhibit epigenetic age acceleration (Horvath
et al., 2015).
Emerging evidence indicates that DNA epigenetic variations in DS
patients also involve 5hmC.
In fact, 5hmC changes contribute to 5mC pattern alterations at
several loci in the DS cerebellum. However, in other genomic regions
changes relate only to 5hmC and, in most cases, a 5hmC loss was ob-
served (Mendioroz et al., 2015). Moreover, reduced 5hmC global levels
have been detected in DS peripheral blood cells (Ciccarone et al.,
2017a), as well as in physiologically aged individuals (Buscarlet et al.,
2016; Valentini et al., 2016; Xiong et al., 2015).
DS-associated 5hmC changes may affect transcriptional regulation.
In fact, increased 5hmC of certain gene loci is positively associated with
transcriptional upregulation in DS (Lu et al., 2016).
3. Putative mechanisms underlying changes of DNA epigenetic
modifications in aging
In the wake of the growing awareness where epigenetic alterations
form the basis for some aging related pathologies, one hypothesis may
be that changes of DNA epigenetic modification signatures lie at the
heart of the aging process.
However, this hypothesis remains tentative because of the current
lack of detailed explanations as to how these changes arise and/or
might relate to molecular events in the cell. Serious limitation is im-
posed by the complexity and diversity of mechanisms governing chro-
matin structure dynamics, which involve many other mechanisms over
and above DNA epigenetic modifications. PTMs of histone tails, non-
coding RNAs and histone positioning are included.
Despite the general lack of any exhaustive evidence, there is an
emerging realisation that DNA epigenetic modifications are highly in-
terrelated with other chromatin modifications such as histone PTMs
and rely mechanistically on them (Rose and Klose, 2014).
That being said, to better understand DNA methylation changes that
occur during aging, investigation of their relationship with chromatin
context is therefore necessary. However, only a few recent studies have
integrated DNA methylation data with information regarding other
epigenetic modifications of chromatin (Avrahami et al., 2015; Sun
et al., 2014; Zhang et al., 2015).
These findings indicate that aging-related DNA methylation sig-
natures correlate with specific histone PTMs, thus suggesting that they
are the result of molecular mechanisms operating within a broader
language of epigenetic modifications of chromatin. This section outlines
a possible molecular rationale for this hypothetical scenario.
3.1. Loss of 5mC
The loss of 5mC in aging is a complex, multifaceted phenomenon. It
may be possible to distinguish two different events: a ‘global' hypo-
methylation involving non-genic repetitive elements of the genome and
a ‘local' loss in gene regions.
It is reasonable to assume that global hypomethylation relates to the
loss of constitutive heterochromatin integrity, a hallmark of aging in-
variably observed in various eukaryotes ranging from yeasts to humans
(Tsurumi and Li, 2012). Notably, age-related loss of heterochromatin is
also observed in organisms lacking DNA methylation (Tsurumi and Li,
2012). This suggests that where methylation is coupled with other
epigenetic mechanisms to ensure heterochromatin condensation, the
aging-related global 5mC loss is probably a consequence rather than a
cause of heterochromatin loss.
In fact, the deposition of 5mC in vertebrates depends on H3K9me3,
a prerequisite for the subsequent methylation of DNA in the constitutive
heterochromatin. This has been attributed to the physical interaction of
DNMT enzymes with components of the H3K9 methylation machinery,
specifically the histone methyltransferase SUV39H1/2 (Chang et al.,
2011; Fuks et al., 2003; Lehnertz et al., 2003; Li et al., 2006). In ad-
dition, H3K9me3 constitutes a platform for the HP1-mediated recruit-
ment of the DNA methylation machinery to chromatin (Smallwood
et al., 2007).
By means of apparently different mechanisms, H3K9me3 is also
important for maintaining heterochromatin 5mC level. In fact,
H3K9me3 at hemi-methylated CG dinucleotides is recognized by the
UHRF1 protein, which recruits DNMT1 thereby favouring full-methy-
lation of DNA immediately after the replication fork passage (Liu et al.,
2013b; Nishiyama et al., 2013; Sharif et al., 2007).
Interplay between histones and DNA methylation machinery is
possibly required for 5mC maintenance even outside the replication
process. Nucleosomes containing CG-rich methylated DNA have the
ability to bind DNMT3A and 3B. Apparently, this mechanism is re-
quired for proper propagation of 5mC in hyper-methylated domains of
the genome. The aim might be to favour cytosine methylation in un-
wanted unmethylated CGs generated either by errors of the replication-
associated maintenance methylation process or by spurious losses of
5mC (Jeong et al., 2009; Jones and Liang, 2009).
In view of this dependence of 5mC patterns on pre-existing histone
PTMs for its establishment and maintenance, an aging-associated hy-
pomethylation due to loss of heterochromatin is therefore a feasible
hypothesis.
In fact, aging seems to undermine many of the elements involved in
this cross talk. Specifically, the aging cells show nucleosome core his-
tone depletion, which causes reduced occupancy and disordered posi-
tioning of residual nucleosomes along the chromatin fibres (Hu et al.,
2014; O'Sullivan et al., 2010). Reduced levels of H3K9me3 are observed
in tissues and cells of aged humans and rodents (Djeghloul et al., 2016;
Scaffidi and Misteli, 2006; Sidler et al., 2013; Sidler et al., 2014; Zhang
et al., 2015). The same event takes place in the cells of HGPS (Scaffidi
and Misteli, 2006; Shumaker et al., 2006) or WS (Zhang et al., 2015)
patients. It is likely that this reflects a down-regulation of SUV39H1/2
(Djeghloul et al., 2016; Sidler et al., 2014) that, in combination with an
age-associated decrease of HP1 (Scaffidi and Misteli, 2006; Zhang et al.,
2015) and of DNMTs (Casillas et al., 2003; Ciccarone et al., 2016; Ronn
et al., 2015; Sun et al., 2014) expression levels, may possibly account
for heterochromatin DNA demethylation.
Accordingly, factors responsible for DNA methylation maintenance
may operate with reduced stringency due to suboptimal dosage over
lifespan, which may result in an increase in inter-individual variability
along with an overall decrease in DNA methylation (Fig. 3A).
The origin of this phenomenon still remains unknown. However,
recent studies suggest the involvement of both transcriptional and post-
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transcriptional mechanisms.
A reduced expression is associated with the acquisition of the re-
pressive mark H3K27me3 at the transcription start sites of histone
genes in muscle stem cells from aged mice (Liu et al., 2013a). Similarly,
a study in human adipose tissue from individuals with an age range of
20-80 years reported that age-related decrease of DNMT transcripts is
associated with the hypermethylation of specific CG sites at the corre-
sponding genes (Ronn et al., 2015). This evidence raises the possibility
Fig. 3. Putative molecular mechanisms underlying age-related DNA methylation changes. A) DNA methylation maintenance processes (upper panel). Immediately after DNA synthesis,
maintenance activity of methyltransferases methylates hemi-methylated CpG sites in a H3K9me3-dependent manner with the help of partner proteins including PCNA, UHRF1 and
SUV39H1. Post-replication, the DNMTs complete the methylation process by correcting errors left by the replication-coupled process and/or due to stochastic loss of 5mC. The DNMTs are
recruited to the chromatin regions containing methylated H3K9 via their interaction with HP1 and SUV39H1. During aging, both mechanisms are impaired (lower panel) due to defective
SUV39H1, HP1, nucleosome core histones and DNMTs. This, in turn, would affect proper propagation of heterochromatin DNA methylation patterns. B) Maintenance of unmethylated
state at CGI-promoters (right panel). CGIs associated with actively transcribed genes are protected from aberrant de novo methylation by multiple, interrelated mechanisms that
collectively conflict with DNMTs’ access and activity. These include action by active histone PTMs, such as H3K4me3, and CxxC protein factors. H3K4me3 is placed by histone
methyltransferases (e.g. SET1A) with the help of specific CxxC transcription factors (TF). Other CxxC protein factors, such as TET enzymes, cause the removal of spurious, unwanted 5mC
via DNA demethylation processes, initiated by 5mC to 5hmC conversion. The hypermethylation of CGIs with age (left panel) is shown as a process by which DNMTs gain access to DNA
due to a weakening of one or more factors that contribute to CGIs protection. These include transcriptional silencing, H3K4me3 loss coupled with H3K27me3 deposition and defects of the
active DNA demethylation processes governed by TET enzymes. The susceptibility of H3K27me3-marked chromatin to gain 5mC relies on the capability of components of the Polycomb
Repressive Complex 2 (PRC2) to recruit DNMTs on chromatin. During aging, these processes would cause a gradual shift of some CGI chromatin configuration towards hetero-
chromatinization with gain of DNA methylation.
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that an altered chromatin state at specific gene loci may precede the
global alteration of 5mC in aging.
A recent study has also shown that the expression of DNMTs is in-
fluenced by the growth hormone, suggesting that age-related growth
hormone dysfunctions may contribute to DNMTs reduction in aging via
the IGF-1/FOXO pathways, which play a profound role in aging
(Armstrong et al., 2014). An additional regulatory mechanism to be
explored in aging epigenetics is the role of p53, whose activation has
been linked to heterochromatin relaxation and H3K9me3 loss via
transcriptional silencing of SUV39H1 (Nicolai et al., 2015; Zheng et al.,
2014).
In addition to transcriptional down-regulation, loss of hetero-
chromatin key factors may also occur through post-translational me-
chanisms.
In human hematopoietic stem cells, the age-related global loss of
H3K9me3 is associated with increased expression of miR-125b, which
acts as a negative regulator of the SUV39H1 transcript level (Djeghloul
et al., 2016). However, at the moment, the mechanism driving up-
regulation of miR-125 with age in human hematopoietic stem cells
remains undiscovered.
In addition, heterochromatin loss may be a derivative of defects of
the nuclear envelope, which provides a special microenvironment for
the establishment, propagation and maintenance of heterochromatin.
This could involve a dysfunction of proteins which safeguard the in-
tegrity of the nuclear lamina and/or its function as a peripheral het-
erochromatin organiser. For example, Lamin A splice variants, that
mimic the mutation of HGPS, increase with age and are associated with
H3K9me3 loss (Scaffidi and Misteli, 2006). Similarly, aging-associated
WRN protein down-regulation leads to destabilisation of hetero-
chromatin by altering the interplay of SUV39H1 and HP1 with the
LAP2β protein, which mediates the interaction of the nuclear lamina
with heterochromatin (Zhang et al., 2015).
Aging-dependent remodelling of heterochromatin and nuclear en-
velope constituents also seems to occur through a more generalised
process of piecemeal degradation of the nucleus, mediated by the au-
tophagosome. It has been suggested that this mechanism participates in
the senescence-induced heterochromatin loss in human fibroblasts (Dou
et al., 2015; Ivanov et al., 2013). However, it is unclear whether it also
contributes to heterochromatin and 5mC loss in physiologically aged
human tissue. This is an important area for future investigation because
it could provide a molecular explanation for the observation that hy-
pomethylation associated with aging and photo-aging of the human
skin involves large blocks of the genome corresponding to the lamina-
associated domains (Vandiver et al., 2015).
An additional promising research area links aging-related chromatin
defects, including heterochromatin loss, to the relocation of epigenetic
machinery in response to DNA damage. In fact, DNA repair requires a
significant amount of chromatin remodelling at damaged sites, which is
achieved by re-positioning several chromatin-remodelling factors away
from their normal housekeeping activities and positions. Consequently,
chronic damage and/or a defective response to it could lead to epige-
nomic changes by titrating away epigenetic enzymes normally needed
for accurate epigenome homeostasis.
This is of particular interest from an aging perspective, as elevated
levels of persistent DNA damage are major aging culprits (Burgess et al.,
2012) and the dominant part of any naturally occurring DNA damage
seems to occur in DNA repeats (Wang et al., 2011).
A mechanism for such global heterochromatin misregulation in
aging may involve the NAD+-dependent histone deacetylase SIRT1 and
the nucleosome remodelling and deacetylase (NuRD) complex. Both
these factors are involved in heterochromatin homeostasis where they
prevent de-repression and aberrant recombination of repeated se-
quences. In mouse embryonic stem cells, SIRT1 is redistributed to DNA
damage sites leading to de-repression of several undamaged loci in-
cluding repetitive DNA and deregulating transcription, in a similar way
to organismal aging (Oberdoerffer et al., 2008).
This process would seem to involve a repressive multiprotein com-
plex containing SIRT1, Polycomb factors and the DNMTs, which was
shown to cause persistent epigenetic changes involving DNA methyla-
tion in response to oxidative stress (O'Hagan et al., 2011).
Similar conclusions can be drawn on the NURD complex, which is
also relocated by DNA damage, favours DNA methylation and whose
deficit has been linked to heterochromatin loss in both HGPS cells and
normal aging (Pegoraro et al., 2009).
This mechanism appears to provide a likely explanation for the re-
lationship between DNA damage and aging. However, recent findings
suggest more complex molecular pathways behind this association. A
further piece of the puzzle is the involvement of the poly(ADP-ribosyl)
ation (PARylation) by PARP enzymes, responsible for NAD+ molecule
conversion to poly-ADP-ribose (PAR) upon binding to damaged DNA.
PAR is conjugated to histones and other proteins in the vicinity of the
DNA lesion and is believed to initiate DNA repair (Ray Chaudhuri and
Nussenzweig, 2017).
PARP1 activation increases with age, probably because of an age-
related accumulation of DNA damage (Fang et al., 2014; Mouchiroud
et al., 2013). This condition may have harmful consequences and
contributes to the aging process. In fact, over-activation of PARP en-
zymes results in NAD+ depletion, which in turn affects SIRT1 activity.
In keeping with this picture, pharmacological inhibition of PARP
enzymes extends lifespan in nematodes (Mouchiroud et al., 2013). In
addition, a compromised balance between PARP1 and SIRT1 signalling
activities contributes to premature aging syndromes (Fang et al., 2014;
Scheibye-Knudsen et al., 2014).
However, whether the PARP-mediated inhibition of SIRT1 trans-
lates into epigenomic changes remains to be seen as yet. In this context,
it would be useful to consider that deregulation of PARP activity may
cause epigenetic changes through alternative pathways. In fact,
PARylation regulates the expression, the catalytic activity and recruit-
ment to chromatin of the DNA modifying enzymes DNMT1 e TET1
(Ciccarone et al., 2014; Ciccarone et al., 2015; Fujiki et al., 2013;
Zampieri et al., 2012; Zampieri et al., 2009). Consistent with this no-
tion, over-activation of PARP enzymes may cause global hypomethy-
lation of the genome (Ciccarone et al., 2012; Guastafierro et al., 2008).
Furthermore, PARP enzymes are thought to be multifunctional mod-
ulators of chromatin structure and some of their functions may be very
relevant in aging. For example, PARylation plays a crucial role in the
establishment and maintenance of heterochromatin (Ciccarone et al.,
2017b; Dantzer and Santoro, 2013).
Putting this knowledge together, it is reasonable to assume that the
5mC global loss is a pernicious consequence of a non-programmed in-
efficiency of the heterochromatin epigenetic maintenance systems.
However, it cannot be ruled out that it may also represent the result of a
regulated process, which could therefore accomplish specific outcomes.
For instance, even though the aging-related loss of DNA repeats me-
thylation can be defined as ‘global’, it actually is not a generalised
phenomenon. In fact, Alu repeats seem to be preferentially targeted
compared to SINE repeats (Bollati et al., 2009; Jintaridth and
Mutirangura, 2010). Moreover, 5mC changes in Alu repeats mainly
occur at specific ages (Jintaridth and Mutirangura, 2010). Whether this
proves that DNA repeats hypomethylation in aging is the outcome of a
regulatory programme still remains to be seen. This seems to be the case
in simple eukaryotes, where activation of transposon elements plays a
major role in the response to stressful environmental conditions (Rey
et al., 2016). Nevertheless, even in vertebrates, the hypermethylated
state of DNA repeats is not an inviolable state either. In fact, in the
physiological setting of mammalian development and differentiation,
Alu repeats demethylation has been shown to be dynamically modu-
lated to regulate transcriptional networks (Garcia-Perez et al., 2016).
Compared to global 5mC loss, the aging-associated site-specific
hypomethylation is even more obscure and probably underestimated.
Indeed, many genome-wide methodologies for DNA methylation ana-
lysis focus on specific tissues, if not on a whole organ. However, most of
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the site-specific changes involve differentially methylated regions spe-
cific to cell types and therefore they may be largely overlooked by
techniques that do not have a population-level cellular resolution. In
fact, site-specific hypomethylation in aging mainly concerns regulatory
regions enriched in H3K4me1, which typically characterises enhancers
that govern tissue-specific genes expression (Fernandez et al., 2015;
Rada-Iglesias et al., 2011). This suggests that aging-associated hypo-
methylation of these regions could result in deregulation of differ-
entiation-related gene expression programmes. Accordingly, a recent
genome-wide analysis of highly purified mice β cells has shown that
genomic regions undergoing age-associated loss of DNA methylation
are distal to promoters and they probably function as enhancers by
binding β cell-specific transcription factors. Significantly, demethyla-
tion of these regions is anticipated by the acquisition of activating
histone marks including H3K4me1 (Avrahami et al., 2015). Parallel
transcriptomic analyses showed that this epigenetic remodelling is as-
sociated with transcriptional upregulation of genes essential for β-cell
identity and function. As a result of that, older mice experience a dra-
matic improvement in β cell function (Avrahami et al., 2015). This
observation is very significant as it suggests that aging can promote
adaptive responses via epigenetic mechanisms.
The fact that site-specific 5mC loss and local H3K4me1 enrichment
regularly correspond indicates that site-specific hypomethylation
probably has an origin distinct from the global hypomethylation. This
may relate to the impairment that all forms of H3K4 methylation cause
to the recruitment of DNMTs on chromatin (Rose and Klose, 2014;
Schubeler, 2015). Alternatively, site-specific hypomethylation may
follow the age-related loss of histone H4 arginine 3 (H4R3) symmetric
dimethylation (H4R3me2s), which specifically recruits the DNA me-
thyltransferase DNMT3A to chromatin in order to suppress gene ex-
pression (Hong et al., 2012; Zhao et al., 2009). Significantly, an
H4R3me2s to H3K4 methylation switch at specific genes is required to
promote differentiation (Dhar et al., 2012). Another possibility is the
intervention of site-specific active demethylation mechanisms. In fact,
it has been proposed that activation of enhancer regions involved in
establishing cell identity and differentiation requires TET-mediated
demethylation (Baumann, 2014). Indeed, some of the binding sites that
are recurrent in aging-associated site-specific hypomethylated regions
are specific to transcription factors capable of causing demethylation
via TET1 recruitment (Ancey et al., 2017; Avrahami et al., 2015).
3.2. Gain of 5mC
The aging-associated hypermethylation is a significantly less fre-
quent phenomenon in the genome but much more specific for gene
sequences than the hypomethylation (Johansson et al., 2013; Li et al.,
2017; Marttila et al., 2015).
CGIs are mainly affected by an increased DNA methylation status,
while it does not immediately influence adjacent regions such as the
CGI-shores and shelves (Li et al., 2017). In fact, the CGIs involved share
distinctive features: i) they are cis-associated to genes with specific
functions (Sun et al., 2014; Zampieri et al., 2015), ii) they are targeted
by repressive chromatin modifications (i.e., H3K27me3) and their re-
lated epigenetic factors (i.e. SUZ12, EZH2) (Beerman et al., 2013;
Dozmorov, 2015; Rakyan et al., 2010; Sun et al., 2014); iii) they share
specific transcription factor sequence motifs (Sun et al., 2014; Yuan
et al., 2015). Surprisingly, for some CGIs the aging-associated hy-
permethylation is a phenomenon that appears to be largely shared
across tissues and species and the degree of their hypermethylation
correlates with the species-specific lifespan (Maegawa et al., 2017).
This suggests that aging interferes with mechanisms that preserve the
non-methylated state of a specific subset of the CGIs. However, drawing
a complete mechanistic picture of these associations is difficult as what
prevents the CGIs from accumulating methyl groups is still unknown.
The first point that needs clarification is the origin of de novo me-
thylation in somatic cells. In fact, this process has long been considered
to be confined to early development. However, recent evidence suggests
the existence of a continuous de novo activity also outside early de-
velopmental stages. Allegedly, this is required for maintaining global
hypermethylation of the genome as an auxiliary mechanism to main-
tenance methylation processes (Jeltsch and Jurkowska, 2014; Jones
and Liang, 2009). However, de novo methylation activity must be
counteracted in the CGIs to preserve their unmethylated state. Such
hypothesis is supported by new findings showing that de novo methy-
lation of some CGIs is the natural outcome when two distinct conditions
occur simultaneously: the interruption of a methylation-blocking ma-
chinery and the repression of transcriptional activity (Takahashi et al.,
2017).
Protection machinery may rely on proteins harbouring the CXXC
(Cys-X-X-Cys, where X is any amino acid) domain, since it has been
proposed that they safeguard the CG clusters within the CGIs from de
novomethylation. One of these proteins is TET1, which localises at CGIs
via its CXXC domain to counteract stochastic DNA methylation events
by promoting active demethylation processes (Williams et al., 2011a).
In addition, it has been proposed that the CXXC finger protein 1 (CFP1)
prevents the recruitment of de novo DNA methyltransferase to CGIs by
promoting the SET1 complex-mediated accumulation of the DNA me-
thylation-blocking histone modification H3K4me3 (Clouaire et al.,
2014; Ooi et al., 2007; Thomson et al., 2010). Of particular importance
is the recent discovery that the F-Box And Leucine-Rich Repeat Protein
10 (FBXL10), which binds nearly all CG-dense promoters via a CXXC
domain, protects Polycomb-occupied CGI promoters from DNA hy-
permethylation (Boulard et al., 2015).
Transcriptional activity also plays a part via the binding of tran-
scription factors (e.g. SP1 (Brandeis et al., 1994)), transcription co-
factors (E.g. PARP1 (Ciccarone et al., 2017b; Krishnakumar et al.,
2008)), Pol2 (Takeshima et al., 2009) and transcripts themselves
(Ginno et al., 2012).
Although there is a lack of direct evidence, the tendency of aging-
related hypermethylation to occur in CGI promoters, targeted by an
H3K27me3-mediated silencing, indicates that aging may interfere with
both mechanisms.
The whole process seemingly give rise to an “epigenetic switch” that
changes the chromatin structure and activity of certain CGI-promoters
from a less stable histone-based transcriptional repression to permanent
DNA methylation silencing, resembling differentiation-linked reg-
ulatory mechanisms that control pluripotency and germ line-specific
genes (Mohn et al., 2008). In aging, this process may involve the well-
known capability of the Polycomb repressor complex to recruit the de
novo DNMTs to CGIs (Vire et al., 2006) coupled with the documented
aging-associated down-regulation of components of the CGI methyla-
tion-blocking machinery, such as TET1 and TDG (Ronn et al., 2015;
Valentini et al., 2016), FBXL10 (Tzatsos et al., 2011) and SP1 (Kim
et al., 2012) (Fig. 3B).
It is very likely that H3K4me3 also plays a part in this process.
Indeed, it has been suggested that hypermethylation of some CGIs in
cancer can be anticipated by an epigenetic silencing, mediated not only
by a gain of H3K27me3 but also by a loss of H3K4me3. Notably, at
every level of H3K27me3 enrichment, CGIs with higher amounts of
H3K4me3 are less methylated than those with lower amounts, in-
dicating that the presence of H3K4me3 has a marked positive effect on
the degree of local resistance to de novo methylation. However, since
the hypermethylated pattern in cancer is initially formed by a slow de
novo methylation process that occurs gradually in normal tissues with
increasing age, both H3K27me3 enrichment and H3K4me3 loss may
represent an epigenetic remodelling that anticipates de novo methyla-
tion in aging (Nejman et al., 2014). This suggests the need to enhance
our knowledge of the importance of H3K4me3 and its regulators in
mammalian aging, which is also indicated by evidence that H3K4me3
modifiers affect longevity in C. elegans and D. melanogaster (Han and
Brunet, 2012). Actually, some findings in human neurons suggest that
the H3K4me3 genomic landscape is altered as a function of age towards
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a predominant loss of H3K4me3 peaks (Cheung et al., 2010).
Site-specific hypermethylation events might also be the con-
sequence of aging-dependent regulatory pathways that use CG methy-
lation as the final step of a transcriptional silencing process. For ex-
ample, cumulative lifetime pro-inflammatory stimuli and stress-related
activation of the glucocorticoid signalling pathway may cause hy-
permethylation of specific loci as a function of age by activating the
STAT3 transcription factor, which is capable of recruiting the DNMTs
on chromatin (Chazaud and Mouchiroud, 2014; Lee et al., 2012). Sig-
nificantly, some CG sites that are part of the epigenetic clock are located
in the glucocorticoids response elements (Zannas et al., 2015).
However, the general age-dependent dynamics of de novo methy-
lation are largely incompatible with a programmed transition of CGIs
chromatin towards a condensed configuration. In fact, accumulation of
methylation on CGIs resembles a gradual process that apparently pro-
ceeds by a series of stochastic CG methylation events causing a pro-
gressive increase in variance and in average DNA methylation of certain
CGIs with increasing age (Nejman et al., 2014; Slieker et al., 2016).
These dynamics of CGIs methylation in aging better fits with an age-
related functional decline of specific epigenetic maintenance systems
that would expose some unmethylated CGIs to an asymmetric, sto-
chastic flux of de novo methylation leading to gradual hypermethyla-
tion.
Nevertheless, the affected regions are well defined and reproducible
across tissues and individuals. This may relate to the existence of a
universal hierarchy of methylation sites in the genome, with every CGI
having its own methylation susceptibility due a specific chromatin
configuration and environment.
Interestingly, this mechanism might open up relevant new research
paths and scenarios for unravelling the link between oxidative stress/
DNA damage with epigenome deregulation in aging. In fact, oxidative
stress has been associated with abnormal methylation due to the
aberrant recruitment of DNMT-containing complexes to low/basal ex-
pression CGI-promoters marked by Polycomb-associated H3K27me3.
Downstream restoration of the unmethylated state requires active de-
methylation involving TET enzymes and the BER mechanisms (Zhang
et al., 2017). In aging, this editing process may be less efficient due to a
defective TET enzymes expression and BER activity (Ronn et al., 2015;
Valentini et al., 2016; Xu et al., 2008). This could result in hy-
permethylation of H3K27me3-marked CG-rich DNA regions as a result
of oxidative stress and may explain the finding that aging-related CGI
hypermethylation, although it is largely driven by tissue-independent
factors, is accelerated by environmental hazards that induce oxidative
stress (Slieker et al., 2016).
The correspondence between different tissues of the genomic sites
which undergo a gradual and age-dependant hypermethylation, may be
explained by a phenomenon of positive selection concerning adult stem
cells and/or progenitor cells. These are multipotent cells involved in
replacing terminally differentiated cells lost by normal tissue attrition.
These cells present H3K27me3-repressed chromatin at common devel-
opmental genes, which tend to resolve upon further differentiation to
grant transcriptional activation and which are required for proper
lineage progression. This epigenetic reprogramming concerns genes
involved in development, differentiation, repression of pluripotency
and self-renewal (Voigt et al., 2013). In this cellular context, aging-
related abnormal methylation of H3K27me3-marked DNA may impair
differentiation, thus resulting in the formation of an abnormal stem
cell/progenitor cell and/or mal-differentiated cells that may hold some
advantageous traits such as cell death resistance and senescence. In an
aged selective tissue microenvironment, these traits would lead to the
expansion of this cell population over time. Such a mechanism has been
proposed as an explanation of how aging may lead to an increased risk
of developing cancer (Nejman et al., 2014).
3.3. From mechanism to patterns: how to integrate molecular models with
the observed methylome dynamics in aging
While it is possible to correlate both aging-associated methylation
losses and gains with multiple, complex chromatin-based mechanisms,
it may also be possible to integrate them into a dynamic scenario that
takes into account the opposing processes of the epigenetic drift and the
epigenetic clock. However, this creates a further level of complexity
that can’t easily be clarified. One possibility is that both the epigenetic
drift and clock share some parts of the same mechanisms.
Indeed, both gain and loss of methylation have a predominant sto-
chastic component that could relate to a certain lack of efficiency of the
epigenetic maintenance mechanisms. This lack of efficiency could be
intrinsic to the system, as in many other biological processes.
Alternatively, it could be caused by aging itself, via deregulation of key
factors involved in the control of epigenetic homeostasis of the genome.
In any case, the result would be an accumulation of DNA methylation
errors over time, which would be consistent with the epigenetic drift
observed in aging.
Conversely, site-specific changes might be the major contributors to
the epigenetic clock. This component of the aging methylome could
easily be derived from programmed or semi-programmed regulatory
processes that ultimately provoke cellular responses to aging-related
stimuli through epigenetic mechanisms. However, the scenario could be
much more complex. On the one hand, it cannot be ruled out that some
site-specific changes may also be involved in the epigenetic drift since
the setting of these processes is the single cell rather than entire organs
and tissues. On the other hand, site-specific changes may also be caused
by stochastic processes due to a differential susceptibility of specific
chromatin regions to either be resistant or be prone to change. Some
changes may be neutral, with no apparent functional consequences, and
therefore be retained passively throughout the life of the cell. For such
events, the reproducibility across cells and tissues could emanate from
the presence in the genome of common sites where the accumulation of
methylation errors can be tolerated within certain limits. Conversely,
other changes may have functional consequences and may undergo
selective mechanisms because they influence cell survival/prolifera-
tion. As a result, these changes may become over-represented in the
aged epigenome. In fact, it is highly likely that the site-specific re-
producible changes observed with aging are happening in adult stem
cells/progenitor cells and are carried into differentiated somatic cells
(Beerman et al., 2013; Issa, 2014; Maegawa et al., 2017). Conversely,
changes that are restricted to differentiated cells would likely be lost
after cell death due to normal turnover of tissues. They would indeed
contribute to an increase in epigenetic noise with age, and also to the
highly reproducible site–specific methylation changes, but to a lesser
extent. Moreover, given that epigenetic programmes are largely
modulated during cellular replication (Gonzalez and Li, 2012), it is
likely that methylation drift also reflects random epigenetic errors ac-
cumulated during stem cell divisions.
More exploration of the “stemness” origin hypothesis of aging-as-
sociated methylation changes will be required to further elucidate this
scenario and clarify how the epigenetic drift and the epigenetic clock
can coexist in the methylomic profile of aged cells and tissues.
4. Conclusions
Epigenetic control of genome functions may have a central role in
aging. However, notwithstanding the evidence that the epigenetic clock
is an excellent lifespan biomarker with potential predictive powers for
mortality, we cannot, as yet, be certain whether epigenetic changes are
“drivers” or whether they are “passengers” in the aging process.
Actually, little is known about which specific cellular dysfunction and
phenotype depend on epigenetic events in aging. Indeed, there is evi-
dence that in some tissue contexts, aging is not accompanied by any
evident DNA methylation drift (Hadad et al., 2016). This raises
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reasonable doubt about the universality of this association. The iden-
tification of molecular mechanisms causally linked to the methylome
changes is an approach that could address the problem because it would
identify molecular processes to be targeted in order to contrast these
changes and to evaluate their impact on the progression of aging. In this
context, it is important to continue with the study of the relationship
between DNA methylation and other epigenetic modifications of
chromatin in aging. The causal-mechanistic view we outline here could
be helpful towards achieving a hierarchical understanding of chromatin
processes underlying methylomic changes in aging. The final goal
would be to trace aging-associated epigenetic changes back to central
regulatory mechanisms, which take control of functions necessary for
the proper orchestration of epigenetic events. This would facilitate the
development of experimental approaches, such as the use of specific
inhibitors of epigenetic enzymes, which can be tested for anti-aging
properties.
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